Investment Advisor
CurrentBIO TRANSCRIPT is a venture capital firm investing in therapeutics in the areas of neurology, rare diseases, and gene therapy.
Please complete the CAPTCHA to continue
@glycomine.com
✓
4 phones found area 415 and 617
✓
LinkedIn matched
A concise factual answer block for searchers comparing this professional profile.
Agnes Rafalko is listed as Drug Discovery & Non-clinical Development | RNA Therapies, Small Molecules & Biologics | Founder of a Rare Disease Company at Bio Transcript, based in Killingworth, Connecticut, United States. AeroLeads shows a work email signal at glycomine.com, phone signal with area code 415, 617, and a matched LinkedIn profile for Agnes Rafalko.
Agnes Rafalko previously worked as Investment Advisor at Bio Transcript and Director of R&D, Rare Genetic Diseases at Mina Therapeutics. Agnes Rafalko holds Ph.D., Biochemistry And Nanomedicine from Northeastern University.
This section adds company-level context without repeating Agnes Rafalko's masked contact details.
AeroLeads found 1 current-domain work email signal for Agnes Rafalko. Compare company email patterns before reaching out.
Dynamic scientist with 15 years of industry experience in successfully navigating the intricate drug development process to advance therapies for multisystemic hereditary diseases from laboratory research to clinical trials. Skilled in the development and execution of research and IND-enabling strategies for lipid nanoparticle based RNA therapies, small molecules, and biologics. Founder of a clinical stage rare disease company. Experienced in leading early-stage biotech operations, developing strategic plans, building highly efficient teams, and securing venture capital funding. Possesses a deep understanding of both established and emerging biotechnologies, along with their associated challenges and market potential.
Listed skills include Analytical Chemistry, Hplc, Bioinformatics, Protein Chemistry, and 6 others.
Company context helps verify the profile and gives searchers a useful next step.
A career timeline built from the work history available for this profile.
London, Gb
BIO TRANSCRIPT is a venture capital firm investing in therapeutics in the areas of neurology, rare diseases, and gene therapy.
London, Gb
MiNA develops small activating RNAs as new medicines for cancer and rare genetic diseases.
San Carlos, California, Us
GLYCOMINE develops small molecule replacement therapies for critical unmet orphan diseases of glycosylation (sugar coating of proteins).
Quick answers generated from the profile data available on this page.
Agnes Rafalko works for Bio Transcript.
Agnes Rafalko is listed as Drug Discovery & Non-clinical Development | RNA Therapies, Small Molecules & Biologics | Founder of a Rare Disease Company at Bio Transcript.
AeroLeads has found 1 work email signal at @glycomine.com for Agnes Rafalko at Bio Transcript.
AeroLeads has found 4 phone signal(s) with area code 415, 617 for Agnes Rafalko at Bio Transcript.
Agnes Rafalko is based in Killingworth, Connecticut, United States while working with Bio Transcript.
Agnes Rafalko has worked for Bio Transcript, Mina Therapeutics, Popcorn Bio, Glycomine Inc., and Biomarin Pharmaceutical Inc..
You can use AeroLeads to view verified contact signals for Agnes Rafalko at Bio Transcript, including work email, phone, and LinkedIn data when available.
Agnes Rafalko holds Ph.D., Biochemistry And Nanomedicine from Northeastern University.
Agnes Rafalko is listed with skills including Analytical Chemistry, Hplc, Bioinformatics, Protein Chemistry, Mass Spectrometry, Lc Ms/Ms, Maldi Tof, and Proteomics.
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial Search contacts